Results 101 to 110 of about 21,523 (223)

Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis

Drug Design, Development and Therapy, 2013
Jamal A Jilani,1 Maha Shomaf,2 Karem H Alzoubi3 1Department of Medicinal Chemistry and Pharmacognosy, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Pathology, Jordan University, Amman, Jordan; 3Department of Clinical Pharmacy,
Jilani JA, Shomaf M, Alzoubi KH
doaj  

Duration of treatment with 5-aminosalicylic acid compounds

World Journal of Gastroenterology, 2007
The development of 5-aminosalicylic acid (5-ASA) therapy as a life long treatment for ulcerative colitis is reviewed from its origins in the 1940s to the present day. The drug was designed to treat rheumatoid arthritis, but was found helpful in the management of nine patients with ulcerative colitis.
Moshkovska, T., Mayberry, J. F.
openaire   +3 more sources

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis [PDF]

, 2017
The clinical validity of drug susceptibility testing (DST) for pyrazinamide, ethambutol, and second-line antituberculosis drugs is uncertain. In an individual patient data meta-analysis of 8955 patients with confirmed multidrug-resistant tuberculosis ...
Ahuja, S., Ahuja, S., Ashkin, D., Ashkin, D., Avendaño, M., Avendaño, M., Banerjee, R., Banerjee, R., Bastos, Mayara L., Bauer, M., Bauer, M., Becerra, M., Becerra, M., Benedetti, A., Benedetti, A., Burgos, M., Burgos, M., Centis, R., Centis, R., Chan, E.D., Chan, E.D., Chiang, C.Y., Chiang, C.Y., Cobelens, F., Cobelens, F., Cox, H., Cox, H., D'Ambrosio, L., D'Ambrosio, L., de Lange, W.C.M., de Lange, W.C.M., DeRiemer, K., DeRiemer, K., Enarson, D., Enarson, D., Falzon, D., Falzon, D., Flanagan, K., Flanagan, K., Flood, J., Flood, J., Gandhi, N., Gandhi, N., Garcia-Garcia, L., Garcia-Garcia, L., Garcia-Garcia, Lourdes, Granich, R.M., Granich, R.M., Hollm-Delgado, M.G., Hollm-Delgado, M.G., Holtz, T.H., Holtz, T.H., Hopewell, P., Hopewell, P., Hussain, Hamidah, Iseman, M., Iseman, M., Jarlsberg, L.G., Jarlsberg, L.G., Keshavjee, S., Keshavjee, S., Kim, H.R., Kim, H.R., Koh, W.J., Koh, W.J., Lancaster, J., Lancaster, J., Lange, C., Lange, C., Leimane, V., Leimane, V., Leimane, Vaira, Leung, C.C., Leung, C.C., Leung, Chi Chiu, Li, J., Li, J., Menzies, D., Menzies, D., Menzies, Dick, Migliori, G.B., Migliori, G.B., Mitnick, C.M., Mitnick, C.M., Narita, M., Narita, M., Narita, Masahiro, Nathanson, E., Nathanson, E., O'Riordan, P., O'Riordan, P., Odendaal, R., Odendaal, R., Pai, M., Pai, M., Palmero, D., Palmero, D., Park, S.K., Park, S.K., Pasvol, G., Pasvol, G., Pena, J., Pena, J., Penã, Jose M., Ponce-de-Leon, A., Ponce-de-Leon, A., Ponce-de-Leon, Alfredo, Pérez-Guzmán, C., Pérez-Guzmán, C., Quelapio, M.I.D., Quelapio, M.I.D., Quy, H.T., Quy, H.T., Riekstina, V., Riekstina, V., Robert, J., Robert, J., Royce, S., Royce, S., Salim, M., Salim, M., Schaaf, H.S., Schaaf, H.S., Seung, K.J., Seung, K.J., Seung, Kwonjune J., Shah, L., Shah, L., Shean, K., Shean, K., Shean, Karen, Shim, T.S., Shim, T.S., Shin, S.S., Shin, S.S., Shiraishi, Y., Shiraishi, Y., Sifuentes-Osornio, J., Sifuentes-Osornio, J., Sifuentes-Osornio, José, Sotgiu, G., Sotgiu, G., Strand, M.J., Strand, M.J., Sung, S.W., Sung, S.W., Tabarsi, P., Tabarsi, P., Tupasi, T.E., Tupasi, T.E., van Altena, R., van Altena, R., van der Walt, M., van der Walt, M., Van der Walt, Martie, van der Werf, T.S., van der Werf, T.S., Van der Werf, Tjip S., Vargas, M.H., Vargas, M.H., Viiklepp, P., Viiklepp, P., Westenhouse, J., Westenhouse, J., Weyer, Karin, Yew, W.W., Yew, W.W., Yew, Wing Wai, Yim, J.J., Yim, J.J.   +169 more
core  

New method for preparation of delivery systems of poorly soluble drugs on the basis of functionalized mesoporous MCM-41 nanoparticles [PDF]

, 2014
MCM-41 silica with spherical morphology and small particle sizes (100 nm) was synthesized and modified by post-synthesis method with amino and/or carboxylic groups.
Aleksandrov, H. E., Konstatantinov, S., Petrova, G. P., Popova, Margarita, Shestakova, Pavleta, Szegedi, Ágnes, Vayssilov, G. N., Yoncheva, Krassimira   +7 more
core   +1 more source

Mesalazine use tactics in the ulcerative colitis patients

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2013
Aim of the lecture. To specify indications for the administration of the 5-aminosalicylic acid (5-АSA) in the patients with ulcerative colitis (UC) and to discuss the possibility of correlation between the body mass index, the disease activity and ...
A. V. Korolev, O. Z. Okhlobystina, L. N. Androsova, O. S. Shifrin   +3 more
doaj  

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors [PDF]

, 2015
OBJECTIVE: Gut barrier is a functional unit organized as a multi-layer system and its multiple functions are crucial for maintaining gut homeostasis. Numerous scientific evidences showed a significant association between gut barrier leaking and gastro ...
Bruno, G, Franceschi, F, Gasbarrini, A, Lopetuso, Lr, Petito, V, Scaldaferri, F   +5 more
core  

Inflammatory Mediators in Inflammatory Bowel Disease

Canadian Journal of Gastroenterology, 1990
Tissue responses to an inflammatory stimulus (such as vasodilation, plasma exudation invasion and activation of inflammatory cells) are elicited by locally synthesized chemical mediators.
BM Peskar
doaj   +1 more source

The choice of treatment approach for mild and moderate ulcerative colitis: A review

Consilium Medicum
Ulcerative colitis (UC) is a chronic immune-inflammatory disease of unknown etiology characterized by continuous non-granulomatous inflammation of the colon mucosa. Inflammation may be limited to the rectum but often extends to the proximal colon.
Oleg V. Golovenko, Irina D. Loranskaia, Alexey M. Osadchuk   +2 more
doaj   +1 more source

Significance of autoimune reactions to pancreatic juice in Crohn`s disease [PDF]

, 1988
Goebell, Harald, Otte, M., Scriba, Peter Christian, Stöcker, W.   +3 more
core   +1 more source

Evaluation of 4-Amino salicylic acid chelating effect on healing of manganese induced intoxications in male Wistar rat's liver [PDF]

, 2012
زمینه و هدف: قرار گرفتن انسان در معرض غبارات منگنز می تواند باعث بروز بیماری شبیه به پارکینسون به نام منگانیسم شود. برای کاهش عوارض حاصل، داروهای شلات کننده‌ی فلزات پیشنهاد شده‌اند.
Eslami farsani, Mohsen., razaviandon, Seyed Mohammad Hossein., Tammadon, Narjes., Yadegari, Sara., Zolfaghari, Mohammad Reza.   +4 more
core